Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Non-residents bought back ₽2.54 billion worth of Russian assets

10/14/24 MOEX

Novabev Group distillery temporarily lost its license

10/14/24 BELU

Artgen Biotech invests in RBT platform

10/11/24 RBTY

Artgen Biotech invests in vaccine creation platform

10/11/24 ABIO

Moscow Exchange has withdrawn from KASE's shareholder structure

10/11/24 MOEX

Positive Technologies will enter the autopentest market

10/11/24 POSI

Aeroflot's passenger traffic in September increased by 16.4%

10/11/24 AFLT

VK fires inefficient employees

10/11/24 VKCO

Magnit opened the first franchise store

10/11/24 MGNT

APRI sales grew by 31% in 9 months

10/11/24 APRI